Eye Allergy Relief Solution/ Drops
NDC Package 11673-430-15
Package Information
Eye Allergy Relief (pheniramine maleate and naphazoline hydrochloride) solution/ dropses is •Adults and children 6 years of age and older: Instill 1 or 2 drops in the affected eye(s) up to 4 times daily.•Children under 6 years: ask a doctor. This formulation utilizes a solution/ drops delivery system. Marketed by Target Corporation, this product is identified by NDC 11673-430 and is authorized under FDA application NDA020065.
Identification & Billing
- RxCUI: 1043704 - naphazoline HCl 0.02675 % / pheniramine maleate 0.315 % Ophthalmic Solution
- RxCUI: 1043704 - naphazoline hydrochloride 0.27 MG/ML / pheniramine maleate 3.15 MG/ML Ophthalmic Solution
- RxCUI: 1043704 - naphazoline HCl 0.027 % / pheniramine maleate 0.315 % Ophthalmic Solution
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 11673 - Target Corporation
- 11673-430 - Eye Allergy Relief
- 11673-430-15 - 1 BOTTLE, DROPPER in 1 CARTON / 15 mL in 1 BOTTLE, DROPPER
- 11673-430 - Eye Allergy Relief
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 11673-430-15 identifies a specific commercial package of 1 bottle, dropper in 1 carton / 15 ml in 1 bottle, dropper of Eye Allergy Relief, a human over the counter drug labeled by Target Corporation. This solution/ drops is formulated for ophthalmic use and contains naphazoline hydrochloride; pheniramine maleate as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Target Corporation on August 31, 2010. The current certification is valid through December 31, 2026.
How is this Target Corporation product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 11673043015. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.